Cas 1822-97-5,3-(4-chlorophenyl)-5-(trichloromethyl)-1,2,4-oxadiazole

1822-97-5

Post Buying Request

Basic information

Product Name: 3-(4-chlorophenyl)-5-(trichloromethyl)-1,2,4-oxadiazole
Synonyms: 3-(4-chlorophenyl)-5-(trichloromethyl)-1,2,4-oxadiazole
CAS NO:1822-97-5
Molecular Formula:
Molecular Weight: 297.956
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-(4-chlorophenyl)-5-(trichloromethyl)-1,2,4-oxadiazole(CAS DataBase Reference)
NIST Chemistry Reference: 3-(4-chlorophenyl)-5-(trichloromethyl)-1,2,4-oxadiazole(1822-97-5)
EPA Substance Registry System: 3-(4-chlorophenyl)-5-(trichloromethyl)-1,2,4-oxadiazole(1822-97-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1822-97-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1822-97-5 Suppliers

Recommended suppliers

1822-97-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1822-97-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,8,2 and 2 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1822-97:
(6*1)+(5*8)+(4*2)+(3*2)+(2*9)+(1*7)=85
85 % 10 = 5
So 1822-97-5 is a valid CAS Registry Number.

1822-97-5Upstream product

1822-97-5Downstream Products

1822-97-5Relevant academic research and scientific papers

From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure-Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II)

Aurelio, Luigi,Scullino, Carmen V.,Pitman, Melissa R.,Sexton, Anna,Oliver, Victoria,Davies, Lorena,Rebello, Richard J.,Furic, Luc,Creek, Darren J.,Pitson, Stuart M.,Flynn, Bernard L.

, p. 965 - 984 (2016)

The sphingosine kinase (SK) inhibitor, SKI-II, has been employed extensively in biological investigations of the role of SK1 and SK2 in disease and has demonstrated impressive anticancer activity in vitro and in vivo. However, interpretations of results u

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1822-97-5